The Hong Kong-listed biotech company rose as much as 29 per cent after rejecting suggestions it poses a national security ...

GenScript Biotech Corporation (HKEX: 1548), a global company providing life science research services and products, biologics development & manufacturing services, and industrial biotechnology ...

PISCATAWAY, N.J., April 14, 2026 /PRNewswire/ -- GenScript Biotech Corporation today announced its 2025 Environmental, Social, and Governance (ESG) Report, positioning the company at the forefront of ...

GenScript Biotech Corporation (HKEX: 1548), a global company providing life science research services and products, biologics development & manufacturing services, and industrial biotechnology ...

Panel discussions brought to life important insights into how AI could change the face of biopharma drug discovery in 2026 and beyond "The conversations throughout the day reinforced that ...

Advancing Climate Action, Governance Excellence, and Global Scientific ImpactPISCATAWAY, N.J., April 14, 2026 /PRNewswire/ -- GenScript Biotech Corporation today announced its 2025 Environmental ...

The average one-year price target for Genscript Biotech (OTCPK:GNNSF) has been revised to $3.32 / share. This is an increase of 16.00% from the prior estimate of $2.86 dated April 1, 2025. The price ...

Genscript Biotech Corp. Quarterly cash flow by MarketWatch. View G51 net cash flow, operating cash flow, operating expenses and cash dividends.

PISCATAWAY, N.J., Nov. 21, 2025 /PRNewswire/ -- GenScript Biotech Corporation, a global leader in life sciences R&D and manufacturing services, successfully hosted the GenScript Biotech Global Forum ...

Genscript Biotech ( (HK:1548)) has shared an update. Genscript Biotech reported that its associate Legend Biotech generated approximately US$597 million in net trade sales from the CARVYKTI® therapy ...